

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 9.55548267 |
| 2 | central nervous system myelination (GO:0022010) | 9.55548267 |
| 3 | fatty acid elongation (GO:0030497) | 6.97282523 |
| 4 | axon ensheathment (GO:0008366) | 6.23210628 |
| 5 | ensheathment of neurons (GO:0007272) | 6.23210628 |
| 6 | myelination (GO:0042552) | 6.18086968 |
| 7 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.57226237 |
| 8 | negative regulation of neurotransmitter secretion (GO:0046929) | 5.13195194 |
| 9 | negative regulation of neurotransmitter transport (GO:0051589) | 4.46461590 |
| 10 | eye photoreceptor cell differentiation (GO:0001754) | 4.31166782 |
| 11 | photoreceptor cell differentiation (GO:0046530) | 4.31166782 |
| 12 | myelin maintenance (GO:0043217) | 4.27314151 |
| 13 | apical protein localization (GO:0045176) | 4.25194602 |
| 14 | response to redox state (GO:0051775) | 4.11618536 |
| 15 | glycerophospholipid catabolic process (GO:0046475) | 4.06091890 |
| 16 | asymmetric protein localization (GO:0008105) | 3.99298507 |
| 17 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.96833373 |
| 18 | oligodendrocyte differentiation (GO:0048709) | 3.90432644 |
| 19 | creatine metabolic process (GO:0006600) | 3.85264551 |
| 20 | negative regulation of protein localization to cell surface (GO:2000009) | 3.75096603 |
| 21 | cholesterol biosynthetic process (GO:0006695) | 3.69711213 |
| 22 | presynaptic membrane organization (GO:0097090) | 3.68955013 |
| 23 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.68647707 |
| 24 | establishment of mitochondrion localization (GO:0051654) | 3.67182871 |
| 25 | astrocyte development (GO:0014002) | 3.63962207 |
| 26 | regulation of collateral sprouting (GO:0048670) | 3.61024635 |
| 27 | L-amino acid import (GO:0043092) | 3.60795603 |
| 28 | presynaptic membrane assembly (GO:0097105) | 3.59522964 |
| 29 | adhesion of symbiont to host cell (GO:0044650) | 3.45264089 |
| 30 | virion attachment to host cell (GO:0019062) | 3.45264089 |
| 31 | neurotransmitter catabolic process (GO:0042135) | 3.41553176 |
| 32 | magnesium ion transport (GO:0015693) | 3.38177540 |
| 33 | glycosylceramide metabolic process (GO:0006677) | 3.33131235 |
| 34 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.30633394 |
| 35 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.26608851 |
| 36 | rhodopsin mediated signaling pathway (GO:0016056) | 3.25739980 |
| 37 | substantia nigra development (GO:0021762) | 3.23515936 |
| 38 | peripheral nervous system axon ensheathment (GO:0032292) | 3.21603368 |
| 39 | myelination in peripheral nervous system (GO:0022011) | 3.21603368 |
| 40 | import into cell (GO:0098657) | 3.21302752 |
| 41 | positive regulation of Rap GTPase activity (GO:0032854) | 3.19797755 |
| 42 | sterol biosynthetic process (GO:0016126) | 3.18312136 |
| 43 | negative regulation of JUN kinase activity (GO:0043508) | 3.18025822 |
| 44 | adult walking behavior (GO:0007628) | 3.11557016 |
| 45 | positive regulation of action potential (GO:0045760) | 3.10975221 |
| 46 | cerebellar granule cell differentiation (GO:0021707) | 3.10006122 |
| 47 | neuronal action potential propagation (GO:0019227) | 3.03447234 |
| 48 | protein palmitoylation (GO:0018345) | 3.02349050 |
| 49 | transmission of nerve impulse (GO:0019226) | 3.01119383 |
| 50 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.98757768 |
| 51 | amyloid precursor protein metabolic process (GO:0042982) | 2.98626171 |
| 52 | negative regulation of macroautophagy (GO:0016242) | 2.98049068 |
| 53 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.97478396 |
| 54 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.97099107 |
| 55 | response to methylmercury (GO:0051597) | 2.94941734 |
| 56 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.91588249 |
| 57 | response to lipoprotein particle (GO:0055094) | 2.90519531 |
| 58 | regulation of dopamine metabolic process (GO:0042053) | 2.88541424 |
| 59 | regulation of catecholamine metabolic process (GO:0042069) | 2.88541424 |
| 60 | regulation of Rap GTPase activity (GO:0032317) | 2.86096928 |
| 61 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.85527557 |
| 62 | membrane tubulation (GO:0097320) | 2.84382915 |
| 63 | isoprenoid biosynthetic process (GO:0008299) | 2.75713145 |
| 64 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.74979196 |
| 65 | synaptic transmission, dopaminergic (GO:0001963) | 2.72891102 |
| 66 | negative regulation of axonogenesis (GO:0050771) | 2.71865075 |
| 67 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.71492392 |
| 68 | negative regulation of cell killing (GO:0031342) | 2.68154606 |
| 69 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.68154606 |
| 70 | histone H2B ubiquitination (GO:0033523) | 2.67590134 |
| 71 | ear development (GO:0043583) | 2.67406411 |
| 72 | detection of light stimulus involved in visual perception (GO:0050908) | 2.65159471 |
| 73 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.65159471 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.64854938 |
| 75 | neuron cell-cell adhesion (GO:0007158) | 2.63796661 |
| 76 | neutrophil activation involved in immune response (GO:0002283) | 2.62367665 |
| 77 | cellular response to ethanol (GO:0071361) | 2.61852600 |
| 78 | Golgi to plasma membrane protein transport (GO:0043001) | 2.61131209 |
| 79 | glial cell development (GO:0021782) | 2.59534094 |
| 80 | relaxation of cardiac muscle (GO:0055119) | 2.58931551 |
| 81 | peptidyl-cysteine modification (GO:0018198) | 2.58514121 |
| 82 | amino acid import (GO:0043090) | 2.57399294 |
| 83 | nucleotide transmembrane transport (GO:1901679) | 2.57305309 |
| 84 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.57118718 |
| 85 | regulation of gamma-delta T cell activation (GO:0046643) | 2.55318490 |
| 86 | GPI anchor metabolic process (GO:0006505) | 2.55227177 |
| 87 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.51724804 |
| 88 | GPI anchor biosynthetic process (GO:0006506) | 2.51603162 |
| 89 | neuron remodeling (GO:0016322) | 2.51423555 |
| 90 | negative regulation of inclusion body assembly (GO:0090084) | 2.50718339 |
| 91 | cellular response to epinephrine stimulus (GO:0071872) | 2.50453313 |
| 92 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.50336680 |
| 93 | adhesion of symbiont to host (GO:0044406) | 2.50281808 |
| 94 | phospholipid homeostasis (GO:0055091) | 2.49775477 |
| 95 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.49709644 |
| 96 | peripheral nervous system development (GO:0007422) | 2.49468941 |
| 97 | neuronal ion channel clustering (GO:0045161) | 2.47837785 |
| 98 | labyrinthine layer development (GO:0060711) | 2.46664761 |
| 99 | macroautophagy (GO:0016236) | 2.46560316 |
| 100 | cellular extravasation (GO:0045123) | 2.45190462 |
| 101 | cyclic nucleotide catabolic process (GO:0009214) | 2.44896742 |
| 102 | organ growth (GO:0035265) | 2.44797043 |
| 103 | behavioral response to cocaine (GO:0048148) | 2.44070849 |
| 104 | mating behavior (GO:0007617) | 2.43104435 |
| 105 | germinal center formation (GO:0002467) | 2.42821018 |
| 106 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.42685374 |
| 107 | positive regulation of receptor recycling (GO:0001921) | 2.40252193 |
| 108 | iron coordination entity transport (GO:1901678) | 2.39991676 |
| 109 | axon development (GO:0061564) | 2.39942544 |
| 110 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.39167937 |
| 111 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.39167937 |
| 112 | phosphatidylserine metabolic process (GO:0006658) | 2.38909774 |
| 113 | ER overload response (GO:0006983) | 2.37965517 |
| 114 | cardiac muscle hypertrophy (GO:0003300) | 2.36378308 |
| 115 | dopamine biosynthetic process (GO:0042416) | 2.35854005 |
| 116 | positive regulation of neurological system process (GO:0031646) | 2.35638401 |
| 117 | thioester biosynthetic process (GO:0035384) | 2.34639051 |
| 118 | acyl-CoA biosynthetic process (GO:0071616) | 2.34639051 |
| 119 | detection of other organism (GO:0098543) | 2.33639355 |
| 120 | regulation of relaxation of muscle (GO:1901077) | 2.31430926 |
| 121 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.28661838 |
| 122 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.26576201 |
| 123 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.26576201 |
| 124 | regulation of ARF protein signal transduction (GO:0032012) | 2.26307232 |
| 125 | positive regulation of chemokine secretion (GO:0090197) | 2.25344321 |
| 126 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.25094124 |
| 127 | striated muscle hypertrophy (GO:0014897) | 2.24754100 |
| 128 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.24154659 |
| 129 | response to epinephrine (GO:0071871) | 2.20722748 |
| 130 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.20471537 |
| 131 | endothelium development (GO:0003158) | 2.19888479 |
| 132 | myofibril assembly (GO:0030239) | 2.19765481 |
| 133 | macrophage activation (GO:0042116) | 2.19345216 |
| 134 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.19158376 |
| 135 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.17726805 |
| 136 | muscle hypertrophy in response to stress (GO:0003299) | 2.17726805 |
| 137 | cardiac muscle adaptation (GO:0014887) | 2.17726805 |
| 138 | macrophage activation involved in immune response (GO:0002281) | 2.17030934 |
| 139 | negative regulation of protein activation cascade (GO:2000258) | 2.15123502 |
| 140 | response to laminar fluid shear stress (GO:0034616) | 2.15040012 |
| 141 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.15016024 |
| 142 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.14945884 |
| 143 | muscle hypertrophy (GO:0014896) | 2.11756761 |
| 144 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.08558811 |
| 145 | detection of bacterium (GO:0016045) | 2.08307599 |
| 146 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.07775567 |
| 147 | negative regulation of complement activation (GO:0045916) | 2.07608421 |
| 148 | mannose metabolic process (GO:0006013) | 2.06667495 |
| 149 | histone H3-K9 demethylation (GO:0033169) | 2.05479447 |
| 150 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.04793401 |
| 151 | regulation of germinal center formation (GO:0002634) | 2.03670490 |
| 152 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.03316373 |
| 153 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.01007671 |
| 154 | positive regulation of fibroblast migration (GO:0010763) | 2.00800406 |
| 155 | detection of molecule of bacterial origin (GO:0032490) | 1.99985246 |
| 156 | regulation of beta-amyloid formation (GO:1902003) | 1.99247682 |
| 157 | regulation of chemokine secretion (GO:0090196) | 1.99216691 |
| 158 | Golgi to endosome transport (GO:0006895) | 1.98754574 |
| 159 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 1.97979209 |
| 160 | establishment of endothelial barrier (GO:0061028) | 1.97496446 |
| 161 | neutrophil activation (GO:0042119) | 1.95992947 |
| 162 | relaxation of muscle (GO:0090075) | 1.95924524 |
| 163 | positive regulation by symbiont of host defense response (GO:0052509) | 1.95846801 |
| 164 | modulation by symbiont of host defense response (GO:0052031) | 1.95846801 |
| 165 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 1.95846801 |
| 166 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 1.95846801 |
| 167 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 1.95846801 |
| 168 | modulation by symbiont of host immune response (GO:0052553) | 1.95846801 |
| 169 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 1.95824000 |
| 170 | cellular response to fluid shear stress (GO:0071498) | 1.95519704 |
| 171 | regulation of clathrin-mediated endocytosis (GO:2000369) | 1.94157116 |
| 172 | negative regulation of humoral immune response (GO:0002921) | 1.93963440 |
| 173 | detection of external biotic stimulus (GO:0098581) | 1.93937686 |
| 174 | angiogenesis involved in wound healing (GO:0060055) | 1.93901353 |
| 175 | actin-myosin filament sliding (GO:0033275) | 1.93070522 |
| 176 | muscle filament sliding (GO:0030049) | 1.93070522 |
| 177 | antigen processing and presentation of endogenous antigen (GO:0019883) | 1.93012532 |
| 178 | regulation of energy homeostasis (GO:2000505) | 1.91971882 |
| 179 | definitive hemopoiesis (GO:0060216) | 1.91765199 |
| 180 | phospholipid efflux (GO:0033700) | 1.91486927 |
| 181 | regulation of platelet aggregation (GO:0090330) | 1.91346207 |
| 182 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 1.90209967 |
| 183 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 1.89677381 |
| 184 | actin filament polymerization (GO:0030041) | 1.89022323 |
| 185 | Rap protein signal transduction (GO:0032486) | 1.88938463 |
| 186 | growth hormone receptor signaling pathway (GO:0060396) | 1.88920968 |
| 187 | regulation of transforming growth factor beta1 production (GO:0032908) | 1.88818979 |
| 188 | protein targeting to Golgi (GO:0000042) | 1.88167415 |
| 189 | cellular response to thyroid hormone stimulus (GO:0097067) | 1.87752945 |
| 190 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 1.87244067 |
| 191 | positive regulation of tolerance induction (GO:0002645) | 1.86544188 |
| 192 | striated muscle adaptation (GO:0014888) | 1.86488919 |
| 193 | interleukin-6-mediated signaling pathway (GO:0070102) | 1.85952485 |
| 194 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 1.83490267 |
| 195 | establishment of protein localization to Golgi (GO:0072600) | 1.83400111 |
| 196 | B cell receptor signaling pathway (GO:0050853) | 1.83024003 |
| 197 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 1.82162659 |
| 198 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 1.81910659 |
| 199 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 1.80933371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.12499539 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.12055347 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.88751337 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.58336583 |
| 5 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.41276263 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.39169860 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.37035671 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.32602947 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.30165552 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.15499679 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.09520096 |
| 12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.97098589 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.96202341 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.89784507 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.87239080 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.87118180 |
| 17 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.85302414 |
| 18 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.84902526 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.83862718 |
| 20 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.83175720 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.82260818 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.82260818 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 1.80936505 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.80871836 |
| 25 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79400573 |
| 26 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.78789521 |
| 27 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.74328330 |
| 28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.67250441 |
| 29 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.66144594 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.65313576 |
| 31 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.63952479 |
| 32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.62033597 |
| 33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.60190229 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.59926463 |
| 35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.59391328 |
| 36 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.57919225 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57896508 |
| 38 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.57505765 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55921824 |
| 40 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.55694676 |
| 41 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.55362867 |
| 42 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.54773571 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.54199856 |
| 44 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.53908799 |
| 45 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.52401146 |
| 46 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.52339807 |
| 47 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.52212304 |
| 48 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.51893226 |
| 49 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.51304472 |
| 50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50304062 |
| 51 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49221695 |
| 52 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.48775436 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.48135367 |
| 54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.48098095 |
| 55 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.46043688 |
| 56 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45808872 |
| 57 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.45439198 |
| 58 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43576975 |
| 59 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.42263600 |
| 60 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.42002176 |
| 61 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.40151572 |
| 62 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.37516071 |
| 63 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.37235187 |
| 64 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.35423316 |
| 65 | STAT3_23295773_ChIP-Seq_U87_Human | 1.34677484 |
| 66 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.34126925 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.33711106 |
| 68 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.33067339 |
| 69 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.32897637 |
| 70 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32556095 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.32086568 |
| 72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27652928 |
| 73 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27641862 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27254565 |
| 75 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26666745 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 1.26218816 |
| 77 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24742733 |
| 78 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.24555684 |
| 79 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23922468 |
| 80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22819961 |
| 81 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.19210478 |
| 82 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.19068740 |
| 83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18766137 |
| 84 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.18671080 |
| 85 | TBL1_22424771_ChIP-Seq_293T_Human | 1.18504868 |
| 86 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.18399159 |
| 87 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18222039 |
| 88 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17602598 |
| 89 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.16319482 |
| 90 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.15401970 |
| 91 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.15284347 |
| 92 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.14978823 |
| 93 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14863496 |
| 94 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.13977011 |
| 95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13935211 |
| 96 | FUS_26573619_Chip-Seq_HEK293_Human | 1.13866920 |
| 97 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.13806187 |
| 98 | P300_19829295_ChIP-Seq_ESCs_Human | 1.13612683 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.12709499 |
| 100 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.12709499 |
| 101 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.11827729 |
| 102 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10746606 |
| 103 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09490240 |
| 104 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09361343 |
| 105 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08490889 |
| 106 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 1.07526234 |
| 107 | * LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06607431 |
| 108 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.06511923 |
| 109 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05560142 |
| 110 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05337099 |
| 111 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05331806 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05183744 |
| 113 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05026852 |
| 114 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04792838 |
| 115 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.04626693 |
| 116 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04257639 |
| 117 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03848481 |
| 118 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.03448379 |
| 119 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.02938209 |
| 120 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.01399195 |
| 121 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.01334760 |
| 122 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00745493 |
| 123 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00745493 |
| 124 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.00321389 |
| 125 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00175554 |
| 126 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98442811 |
| 127 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97880573 |
| 128 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97568854 |
| 129 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.96675000 |
| 130 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96567810 |
| 131 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96476229 |
| 132 | * SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.96333124 |
| 133 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.95591550 |
| 134 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95275726 |
| 135 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95240896 |
| 136 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94934300 |
| 137 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.94391642 |
| 138 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.93951789 |
| 139 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.93935829 |
| 140 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93463759 |
| 141 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93248921 |
| 142 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92836315 |
| 143 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.92829451 |
| 144 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92752928 |
| 145 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.92728939 |
| 146 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.92506248 |
| 147 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.92347864 |
| 148 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.92334022 |
| 149 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.91676488 |
| 150 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.91537611 |
| 151 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91483096 |
| 152 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.91425672 |
| 153 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.91417385 |
| 154 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90956628 |
| 155 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.90694285 |
| 156 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.90590047 |
| 157 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.90123289 |
| 158 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.87448016 |
| 159 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.87139448 |
| 160 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.85732208 |
| 161 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85594554 |
| 162 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.84420291 |
| 163 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.84073628 |
| 164 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.83858025 |
| 165 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.83470084 |
| 166 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82846454 |
| 167 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.81664372 |
| 168 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80817715 |
| 169 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.80585111 |
| 170 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80408397 |
| 171 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.80383295 |
| 172 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.80228252 |
| 173 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.80194726 |
| 174 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80088082 |
| 175 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.79008593 |
| 176 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.78801871 |
| 177 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.78063766 |
| 178 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.77404077 |
| 179 | TP53_16413492_ChIP-PET_HCT116_Human | 0.76933195 |
| 180 | MYB_26560356_Chip-Seq_TH2_Human | 0.76666483 |
| 181 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.75865902 |
| 182 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.74776957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 4.57386132 |
| 2 | MP0003950_abnormal_plasma_membrane | 3.89778418 |
| 3 | MP0003880_abnormal_central_pattern | 3.73104843 |
| 4 | MP0004270_analgesia | 3.44791417 |
| 5 | MP0003724_increased_susceptibility_to | 3.32829698 |
| 6 | MP0004510_myositis | 3.04349004 |
| 7 | MP0005451_abnormal_body_composition | 2.98620433 |
| 8 | MP0004885_abnormal_endolymph | 2.86805028 |
| 9 | MP0003828_pulmonary_edema | 2.75569420 |
| 10 | MP0005551_abnormal_eye_electrophysiolog | 2.75239475 |
| 11 | MP0003690_abnormal_glial_cell | 2.68586214 |
| 12 | MP0003329_amyloid_beta_deposits | 2.52018188 |
| 13 | MP0001529_abnormal_vocalization | 2.51806846 |
| 14 | MP0002272_abnormal_nervous_system | 2.44427506 |
| 15 | MP0004859_abnormal_synaptic_plasticity | 2.44379289 |
| 16 | MP0001486_abnormal_startle_reflex | 2.40409589 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.39175019 |
| 18 | MP0001905_abnormal_dopamine_level | 2.37417496 |
| 19 | MP0005464_abnormal_platelet_physiology | 2.26256110 |
| 20 | MP0003303_peritoneal_inflammation | 2.25060905 |
| 21 | MP0004742_abnormal_vestibular_system | 2.17994043 |
| 22 | MP0002229_neurodegeneration | 2.17625721 |
| 23 | MP0008260_abnormal_autophagy | 2.17225993 |
| 24 | MP0002064_seizures | 2.16856504 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.16046718 |
| 26 | MP0003634_abnormal_glial_cell | 2.14448973 |
| 27 | MP0004130_abnormal_muscle_cell | 2.13852511 |
| 28 | MP0003136_yellow_coat_color | 2.13600957 |
| 29 | MP0001485_abnormal_pinna_reflex | 2.12358896 |
| 30 | MP0002009_preneoplasia | 2.11896076 |
| 31 | MP0004084_abnormal_cardiac_muscle | 2.09167548 |
| 32 | MP0008004_abnormal_stomach_pH | 2.08280820 |
| 33 | MP0009046_muscle_twitch | 2.05236693 |
| 34 | MP0002822_catalepsy | 2.02779185 |
| 35 | MP0010678_abnormal_skin_adnexa | 1.99973145 |
| 36 | MP0004484_altered_response_of | 1.93979553 |
| 37 | MP0003635_abnormal_synaptic_transmissio | 1.86232700 |
| 38 | MP0002734_abnormal_mechanical_nocicepti | 1.78319747 |
| 39 | MP0005423_abnormal_somatic_nervous | 1.77685617 |
| 40 | MP0003436_decreased_susceptibility_to | 1.75166049 |
| 41 | MP0004043_abnormal_pH_regulation | 1.75070758 |
| 42 | MP0005171_absent_coat_pigmentation | 1.72319435 |
| 43 | MP0000383_abnormal_hair_follicle | 1.72313804 |
| 44 | MP0000465_gastrointestinal_hemorrhage | 1.71500189 |
| 45 | MP0005670_abnormal_white_adipose | 1.70185367 |
| 46 | MP0009745_abnormal_behavioral_response | 1.68458172 |
| 47 | MP0004142_abnormal_muscle_tone | 1.66673892 |
| 48 | MP0005409_darkened_coat_color | 1.66600238 |
| 49 | MP0003172_abnormal_lysosome_physiology | 1.61795756 |
| 50 | MP0000778_abnormal_nervous_system | 1.61560464 |
| 51 | MP0003045_fibrosis | 1.60499960 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.58733870 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.57964377 |
| 54 | MP0006072_abnormal_retinal_apoptosis | 1.57443102 |
| 55 | MP0001661_extended_life_span | 1.53945463 |
| 56 | MP0003632_abnormal_nervous_system | 1.53907511 |
| 57 | MP0000462_abnormal_digestive_system | 1.51611282 |
| 58 | MP0005253_abnormal_eye_physiology | 1.51457347 |
| 59 | MP0003646_muscle_fatigue | 1.40396564 |
| 60 | MP0004924_abnormal_behavior | 1.40236429 |
| 61 | MP0005386_behavior/neurological_phenoty | 1.40236429 |
| 62 | MP0010329_abnormal_lipoprotein_level | 1.40026092 |
| 63 | MP0010368_abnormal_lymphatic_system | 1.39932061 |
| 64 | MP0002882_abnormal_neuron_morphology | 1.39667825 |
| 65 | MP0001440_abnormal_grooming_behavior | 1.37134429 |
| 66 | MP0002419_abnormal_innate_immunity | 1.37074370 |
| 67 | MP0005195_abnormal_posterior_eye | 1.36190442 |
| 68 | MP0002063_abnormal_learning/memory/cond | 1.34509094 |
| 69 | MP0002166_altered_tumor_susceptibility | 1.33863037 |
| 70 | MP0002572_abnormal_emotion/affect_behav | 1.33839154 |
| 71 | MP0002332_abnormal_exercise_endurance | 1.32693196 |
| 72 | MP0005666_abnormal_adipose_tissue | 1.32433084 |
| 73 | MP0004215_abnormal_myocardial_fiber | 1.31245684 |
| 74 | MP0004381_abnormal_hair_follicle | 1.28657231 |
| 75 | MP0000747_muscle_weakness | 1.27957899 |
| 76 | MP0002752_abnormal_somatic_nervous | 1.24838671 |
| 77 | MP0000955_abnormal_spinal_cord | 1.24295534 |
| 78 | MP0002972_abnormal_cardiac_muscle | 1.22930968 |
| 79 | MP0001835_abnormal_antigen_presentation | 1.22292694 |
| 80 | MP0002067_abnormal_sensory_capabilities | 1.21821029 |
| 81 | MP0005365_abnormal_bile_salt | 1.21509072 |
| 82 | MP0002998_abnormal_bone_remodeling | 1.21418074 |
| 83 | MP0001346_abnormal_lacrimal_gland | 1.20293883 |
| 84 | MP0002066_abnormal_motor_capabilities/c | 1.19765381 |
| 85 | MP0003763_abnormal_thymus_physiology | 1.19113888 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 1.18998679 |
| 87 | MP0001986_abnormal_taste_sensitivity | 1.18127558 |
| 88 | MP0003879_abnormal_hair_cell | 1.17539822 |
| 89 | MP0003075_altered_response_to | 1.17269249 |
| 90 | MP0004145_abnormal_muscle_electrophysio | 1.16692613 |
| 91 | MP0002127_abnormal_cardiovascular_syste | 1.16284538 |
| 92 | MP0001963_abnormal_hearing_physiology | 1.15824452 |
| 93 | MP0001299_abnormal_eye_distance/ | 1.15315133 |
| 94 | MP0005000_abnormal_immune_tolerance | 1.15154903 |
| 95 | MP0001533_abnormal_skeleton_physiology | 1.14404818 |
| 96 | MP0005410_abnormal_fertilization | 1.14189935 |
| 97 | MP0004087_abnormal_muscle_fiber | 1.13615981 |
| 98 | MP0002106_abnormal_muscle_physiology | 1.13034291 |
| 99 | MP0003183_abnormal_peptide_metabolism | 1.12470865 |
| 100 | MP0005535_abnormal_body_temperature | 1.12392857 |
| 101 | MP0005025_abnormal_response_to | 1.11771034 |
| 102 | MP0001502_abnormal_circadian_rhythm | 1.11615641 |
| 103 | MP0003718_maternal_effect | 1.11374775 |
| 104 | MP0002971_abnormal_brown_adipose | 1.11269295 |
| 105 | MP0003631_nervous_system_phenotype | 1.10871129 |
| 106 | MP0008569_lethality_at_weaning | 1.10392839 |
| 107 | MP0009780_abnormal_chondrocyte_physiolo | 1.09721145 |
| 108 | MP0001800_abnormal_humoral_immune | 1.09137610 |
| 109 | MP0006082_CNS_inflammation | 1.08874504 |
| 110 | MP0000647_abnormal_sebaceous_gland | 1.07655963 |
| 111 | MP0004036_abnormal_muscle_relaxation | 1.07124990 |
| 112 | MP0003938_abnormal_ear_development | 1.06975633 |
| 113 | MP0002090_abnormal_vision | 1.06752318 |
| 114 | MP0000604_amyloidosis | 1.06058080 |
| 115 | MP0005620_abnormal_muscle_contractility | 1.05651501 |
| 116 | MP0005166_decreased_susceptibility_to | 1.05104246 |
| 117 | MP0001970_abnormal_pain_threshold | 1.05055331 |
| 118 | MP0005387_immune_system_phenotype | 1.03848204 |
| 119 | MP0001790_abnormal_immune_system | 1.03848204 |
| 120 | MP0000751_myopathy | 1.03642859 |
| 121 | MP0010630_abnormal_cardiac_muscle | 1.02944292 |
| 122 | MP0003656_abnormal_erythrocyte_physiolo | 1.02918621 |
| 123 | MP0003279_aneurysm | 1.02851299 |
| 124 | MP0004947_skin_inflammation | 1.02103789 |
| 125 | MP0003011_delayed_dark_adaptation | 1.01292353 |
| 126 | MP0004147_increased_porphyrin_level | 1.00525424 |
| 127 | MP0004883_abnormal_blood_vessel | 1.00509810 |
| 128 | MP0002118_abnormal_lipid_homeostasis | 0.99530130 |
| 129 | MP0005085_abnormal_gallbladder_physiolo | 0.98806525 |
| 130 | MP0003091_abnormal_cell_migration | 0.98193853 |
| 131 | MP0010155_abnormal_intestine_physiology | 0.97621284 |
| 132 | MP0002723_abnormal_immune_serum | 0.96237698 |
| 133 | MP0005375_adipose_tissue_phenotype | 0.95611587 |
| 134 | MP0000749_muscle_degeneration | 0.94916909 |
| 135 | MP0002933_joint_inflammation | 0.94282258 |
| 136 | MP0002405_respiratory_system_inflammati | 0.93918860 |
| 137 | MP0001765_abnormal_ion_homeostasis | 0.93550275 |
| 138 | MP0001177_atelectasis | 0.93099588 |
| 139 | MP0000249_abnormal_blood_vessel | 0.92963735 |
| 140 | MP0005164_abnormal_response_to | 0.91965152 |
| 141 | MP0001879_abnormal_lymphatic_vessel | 0.90559762 |
| 142 | MP0005369_muscle_phenotype | 0.90156811 |
| 143 | MP0009115_abnormal_fat_cell | 0.90038028 |
| 144 | MP0003866_abnormal_defecation | 0.89966281 |
| 145 | MP0005385_cardiovascular_system_phenoty | 0.89825198 |
| 146 | MP0001544_abnormal_cardiovascular_syste | 0.89825198 |
| 147 | MP0000566_synostosis | 0.89523558 |
| 148 | MP0003868_abnormal_feces_composition | 0.89297273 |
| 149 | MP0003195_calcinosis | 0.89232615 |
| 150 | MP0003787_abnormal_imprinting | 0.88784115 |
| 151 | MP0001545_abnormal_hematopoietic_system | 0.88630261 |
| 152 | MP0005397_hematopoietic_system_phenotyp | 0.88630261 |
| 153 | MP0002420_abnormal_adaptive_immunity | 0.88452552 |
| 154 | MP0003633_abnormal_nervous_system | 0.88431066 |
| 155 | MP0002909_abnormal_adrenal_gland | 0.88415830 |
| 156 | MP0008775_abnormal_heart_ventricle | 0.88061826 |
| 157 | MP0004185_abnormal_adipocyte_glucose | 0.86649060 |
| 158 | MP0005058_abnormal_lysosome_morphology | 0.86142875 |
| 159 | MP0001819_abnormal_immune_cell | 0.85678489 |
| 160 | MP0003937_abnormal_limbs/digits/tail_de | 0.85598591 |
| 161 | MP0002452_abnormal_antigen_presenting | 0.84895752 |
| 162 | MP0000013_abnormal_adipose_tissue | 0.83775495 |
| 163 | MP0002733_abnormal_thermal_nociception | 0.83155376 |
| 164 | MP0001501_abnormal_sleep_pattern | 0.82996445 |
| 165 | MP0009840_abnormal_foam_cell | 0.80116177 |
| 166 | MP0002152_abnormal_brain_morphology | 0.77568201 |
| 167 | MP0005646_abnormal_pituitary_gland | 0.76155483 |
| 168 | MP0000026_abnormal_inner_ear | 0.74952419 |
| 169 | MP0004085_abnormal_heartbeat | 0.73825334 |
| 170 | MP0005391_vision/eye_phenotype | 0.71245512 |
| 171 | MP0000003_abnormal_adipose_tissue | 0.69226238 |
| 172 | MP0001851_eye_inflammation | 0.68293895 |
| 173 | MP0005408_hypopigmentation | 0.66620792 |
| 174 | MP0000579_abnormal_nail_morphology | 0.66189176 |
| 175 | MP0005623_abnormal_meninges_morphology | 0.65814124 |
| 176 | MP0003137_abnormal_impulse_conducting | 0.65578842 |
| 177 | MP0006138_congestive_heart_failure | 0.63523303 |
| 178 | MP0002184_abnormal_innervation | 0.60600794 |
| 179 | MP0001968_abnormal_touch/_nociception | 0.56557144 |
| 180 | MP0004272_abnormal_basement_membrane | 0.55791704 |
| 181 | MP0003806_abnormal_nucleotide_metabolis | 0.55672220 |
| 182 | MP0005330_cardiomyopathy | 0.55596028 |
| 183 | MP0002796_impaired_skin_barrier | 0.55462896 |
| 184 | MP0000762_abnormal_tongue_morphology | 0.55114127 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.92370225 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.92370225 |
| 3 | Neurofibrillary tangles (HP:0002185) | 5.24701282 |
| 4 | Sensory axonal neuropathy (HP:0003390) | 4.60495350 |
| 5 | Abnormality of the corticospinal tract (HP:0002492) | 4.47011064 |
| 6 | Parakeratosis (HP:0001036) | 4.28150286 |
| 7 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.09569713 |
| 8 | Cerebral hypomyelination (HP:0006808) | 4.09177680 |
| 9 | Peripheral hypomyelination (HP:0007182) | 3.89937509 |
| 10 | Onion bulb formation (HP:0003383) | 3.79120044 |
| 11 | Prolonged bleeding time (HP:0003010) | 3.71040503 |
| 12 | Cerebral inclusion bodies (HP:0100314) | 3.67926814 |
| 13 | Spastic gait (HP:0002064) | 3.48931403 |
| 14 | Spontaneous hematomas (HP:0007420) | 3.44534532 |
| 15 | Gingival bleeding (HP:0000225) | 3.39992521 |
| 16 | Insidious onset (HP:0003587) | 3.38533848 |
| 17 | Termporal pattern (HP:0011008) | 3.38533848 |
| 18 | Congenital stationary night blindness (HP:0007642) | 3.30164454 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.29725347 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.26755109 |
| 21 | Intention tremor (HP:0002080) | 3.23787662 |
| 22 | Exercise-induced myalgia (HP:0003738) | 3.19787526 |
| 23 | Dysmetria (HP:0001310) | 3.10834220 |
| 24 | Myokymia (HP:0002411) | 3.09737159 |
| 25 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.05867102 |
| 26 | Spastic paraparesis (HP:0002313) | 3.04471543 |
| 27 | Difficulty running (HP:0009046) | 3.01431983 |
| 28 | Papilledema (HP:0001085) | 3.00109744 |
| 29 | Abnormal auditory evoked potentials (HP:0006958) | 2.99686796 |
| 30 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.96194284 |
| 31 | Epistaxis (HP:0000421) | 2.95524846 |
| 32 | Akinesia (HP:0002304) | 2.95269059 |
| 33 | Muscle fiber inclusion bodies (HP:0100299) | 2.91632426 |
| 34 | Nemaline bodies (HP:0003798) | 2.87772714 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 2.84289122 |
| 36 | Hematochezia (HP:0002573) | 2.83271707 |
| 37 | Bundle branch block (HP:0011710) | 2.81618864 |
| 38 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.80683004 |
| 39 | Alacrima (HP:0000522) | 2.74844595 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.71088388 |
| 41 | Muscle fiber splitting (HP:0003555) | 2.68961904 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.68883825 |
| 43 | Split foot (HP:0001839) | 2.68408833 |
| 44 | Thickened helices (HP:0000391) | 2.67027254 |
| 45 | Slow saccadic eye movements (HP:0000514) | 2.65035776 |
| 46 | Menorrhagia (HP:0000132) | 2.62104612 |
| 47 | Ankle clonus (HP:0011448) | 2.60757153 |
| 48 | CNS hypomyelination (HP:0003429) | 2.58506707 |
| 49 | Scanning speech (HP:0002168) | 2.53858713 |
| 50 | Ventricular fibrillation (HP:0001663) | 2.53697700 |
| 51 | Anteriorly placed anus (HP:0001545) | 2.52380404 |
| 52 | Amyloidosis (HP:0011034) | 2.46779811 |
| 53 | Testicular neoplasm (HP:0010788) | 2.46061419 |
| 54 | Stomatitis (HP:0010280) | 2.45846539 |
| 55 | Hyperlipoproteinemia (HP:0010980) | 2.45047225 |
| 56 | Sudden death (HP:0001699) | 2.43729304 |
| 57 | Pheochromocytoma (HP:0002666) | 2.38529626 |
| 58 | Abnormality of the common coagulation pathway (HP:0010990) | 2.37806702 |
| 59 | Purpura (HP:0000979) | 2.36910289 |
| 60 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.34792780 |
| 61 | Subaortic stenosis (HP:0001682) | 2.34792780 |
| 62 | Abnormality of macular pigmentation (HP:0008002) | 2.33578597 |
| 63 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.33281977 |
| 64 | Abolished electroretinogram (ERG) (HP:0000550) | 2.32532249 |
| 65 | Autoamputation (HP:0001218) | 2.32168077 |
| 66 | Recurrent abscess formation (HP:0002722) | 2.31341899 |
| 67 | Recurrent bacterial skin infections (HP:0005406) | 2.30708629 |
| 68 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.29579557 |
| 69 | Focal motor seizures (HP:0011153) | 2.28260408 |
| 70 | Poor speech (HP:0002465) | 2.24705419 |
| 71 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.23565371 |
| 72 | Ventricular tachycardia (HP:0004756) | 2.23185036 |
| 73 | EMG: myopathic abnormalities (HP:0003458) | 2.22980195 |
| 74 | Episodic fever (HP:0001954) | 2.22730384 |
| 75 | Joint hemorrhage (HP:0005261) | 2.22670790 |
| 76 | Ventricular arrhythmia (HP:0004308) | 2.21309453 |
| 77 | Generalized myoclonic seizures (HP:0002123) | 2.20944937 |
| 78 | Decreased lacrimation (HP:0000633) | 2.18087597 |
| 79 | Paraparesis (HP:0002385) | 2.17656591 |
| 80 | Abnormal platelet volume (HP:0011876) | 2.16757350 |
| 81 | Dysostosis multiplex (HP:0000943) | 2.16163970 |
| 82 | Spastic tetraparesis (HP:0001285) | 2.15882122 |
| 83 | Cerebral hemorrhage (HP:0001342) | 2.14854646 |
| 84 | Papillary thyroid carcinoma (HP:0002895) | 2.11766491 |
| 85 | Increased CSF protein (HP:0002922) | 2.11045135 |
| 86 | Action tremor (HP:0002345) | 2.10863854 |
| 87 | Gastrointestinal infarctions (HP:0005244) | 2.10435014 |
| 88 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09929139 |
| 89 | Mucopolysacchariduria (HP:0008155) | 2.09929139 |
| 90 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.09846252 |
| 91 | Aplasia of the phalanges of the hand (HP:0009802) | 2.09846252 |
| 92 | Aplasia involving bones of the extremities (HP:0009825) | 2.09846252 |
| 93 | Obstructive sleep apnea (HP:0002870) | 2.09636768 |
| 94 | Epileptic encephalopathy (HP:0200134) | 2.08229207 |
| 95 | Lower limb muscle weakness (HP:0007340) | 2.07146389 |
| 96 | Absent septum pellucidum (HP:0001331) | 2.06964783 |
| 97 | Increased circulating renin level (HP:0000848) | 2.06117312 |
| 98 | Abnormality of the calf musculature (HP:0001430) | 2.05098007 |
| 99 | Erythroderma (HP:0001019) | 2.04424346 |
| 100 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.03691599 |
| 101 | Clumsiness (HP:0002312) | 2.03528961 |
| 102 | Retinal dysplasia (HP:0007973) | 2.03416026 |
| 103 | Distal lower limb muscle weakness (HP:0009053) | 2.02603591 |
| 104 | Increased serum pyruvate (HP:0003542) | 2.02509850 |
| 105 | Abnormality of glycolysis (HP:0004366) | 2.02509850 |
| 106 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.02087200 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.02087200 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.02087200 |
| 109 | Neuroendocrine neoplasm (HP:0100634) | 2.02029105 |
| 110 | Increased mean platelet volume (HP:0011877) | 2.01924301 |
| 111 | Premature skin wrinkling (HP:0100678) | 2.00803461 |
| 112 | Right ventricular cardiomyopathy (HP:0011663) | 2.00704192 |
| 113 | Decreased central vision (HP:0007663) | 2.00423594 |
| 114 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.00081866 |
| 115 | Atonic seizures (HP:0010819) | 1.99316619 |
| 116 | Myositis (HP:0100614) | 1.99294567 |
| 117 | Central scotoma (HP:0000603) | 1.97402661 |
| 118 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.96460899 |
| 119 | Hyperkalemia (HP:0002153) | 1.95539207 |
| 120 | Increased variability in muscle fiber diameter (HP:0003557) | 1.95098697 |
| 121 | Pulmonary embolism (HP:0002204) | 1.94995526 |
| 122 | Cupped ear (HP:0000378) | 1.94379921 |
| 123 | Calf muscle hypertrophy (HP:0008981) | 1.93684145 |
| 124 | Gingivitis (HP:0000230) | 1.92580996 |
| 125 | Heart block (HP:0012722) | 1.92394614 |
| 126 | Type 1 muscle fiber predominance (HP:0003803) | 1.92125255 |
| 127 | Systemic lupus erythematosus (HP:0002725) | 1.90391540 |
| 128 | Clonus (HP:0002169) | 1.87707305 |
| 129 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.86998631 |
| 130 | Congenital sensorineural hearing impairment (HP:0008527) | 1.86967620 |
| 131 | Vaginal atresia (HP:0000148) | 1.86910371 |
| 132 | Coronal craniosynostosis (HP:0004440) | 1.86757013 |
| 133 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.86585135 |
| 134 | Decreased motor nerve conduction velocity (HP:0003431) | 1.85954163 |
| 135 | Malnutrition (HP:0004395) | 1.85889375 |
| 136 | Petechiae (HP:0000967) | 1.85758402 |
| 137 | Leukodystrophy (HP:0002415) | 1.85041704 |
| 138 | Adrenal hypoplasia (HP:0000835) | 1.84849525 |
| 139 | Bowel incontinence (HP:0002607) | 1.84511164 |
| 140 | Prolonged neonatal jaundice (HP:0006579) | 1.83873623 |
| 141 | EMG: neuropathic changes (HP:0003445) | 1.83707756 |
| 142 | Dysmetric saccades (HP:0000641) | 1.83656005 |
| 143 | Chest pain (HP:0100749) | 1.83070801 |
| 144 | Hyperglycemia (HP:0003074) | 1.82807936 |
| 145 | Retrobulbar optic neuritis (HP:0100654) | 1.82557580 |
| 146 | Optic neuritis (HP:0100653) | 1.82557580 |
| 147 | Syncope (HP:0001279) | 1.82139531 |
| 148 | Visceral angiomatosis (HP:0100761) | 1.82132533 |
| 149 | Hypomagnesemia (HP:0002917) | 1.82061619 |
| 150 | Synostosis involving the elbow (HP:0003938) | 1.82006196 |
| 151 | Humeroradial synostosis (HP:0003041) | 1.82006196 |
| 152 | Orchitis (HP:0100796) | 1.81271083 |
| 153 | Morphological abnormality of the inner ear (HP:0011390) | 1.81052808 |
| 154 | Abnormality of the septum pellucidum (HP:0007375) | 1.80668652 |
| 155 | Abnormal large intestine physiology (HP:0012700) | 1.79691139 |
| 156 | Genital tract atresia (HP:0001827) | 1.79532371 |
| 157 | Dyschromatopsia (HP:0007641) | 1.79314584 |
| 158 | Distal sensory impairment (HP:0002936) | 1.78969899 |
| 159 | Hypercortisolism (HP:0001578) | 1.78296039 |
| 160 | Diminished movement (HP:0002374) | 1.78140291 |
| 161 | Dysdiadochokinesis (HP:0002075) | 1.78123337 |
| 162 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.78115544 |
| 163 | Facial diplegia (HP:0001349) | 1.76921805 |
| 164 | Mitral stenosis (HP:0001718) | 1.76787039 |
| 165 | Hyporeflexia of lower limbs (HP:0002600) | 1.74798569 |
| 166 | Joint swelling (HP:0001386) | 1.72856726 |
| 167 | Deep venous thrombosis (HP:0002625) | 1.72517132 |
| 168 | Complement deficiency (HP:0004431) | 1.72511727 |
| 169 | Infantile muscular hypotonia (HP:0008947) | 1.71744440 |
| 170 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.71257572 |
| 171 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.71167024 |
| 172 | Hypoplastic pelvis (HP:0008839) | 1.70856468 |
| 173 | Abnormal atrioventricular conduction (HP:0005150) | 1.70853738 |
| 174 | Spontaneous abortion (HP:0005268) | 1.70604400 |
| 175 | Vertigo (HP:0002321) | 1.70046802 |
| 176 | Metabolic alkalosis (HP:0200114) | 1.70023243 |
| 177 | Megalencephaly (HP:0001355) | 1.69625592 |
| 178 | Polycythemia (HP:0001901) | 1.69546271 |
| 179 | Hypoglycemic seizures (HP:0002173) | 1.68893368 |
| 180 | Postnatal microcephaly (HP:0005484) | 1.68200034 |
| 181 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.68004416 |
| 182 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.67025108 |
| 183 | Gowers sign (HP:0003391) | 1.66583125 |
| 184 | Tetraparesis (HP:0002273) | 1.65600699 |
| 185 | Frequent falls (HP:0002359) | 1.65135671 |
| 186 | Foot dorsiflexor weakness (HP:0009027) | 1.65064284 |
| 187 | Broad-based gait (HP:0002136) | 1.64648141 |
| 188 | Choroideremia (HP:0001139) | 1.64587512 |
| 189 | Arterial thrombosis (HP:0004420) | 1.64584726 |
| 190 | Cone-rod dystrophy (HP:0000548) | 1.63979417 |
| 191 | Hypokalemic alkalosis (HP:0001949) | 1.63942904 |
| 192 | Striae distensae (HP:0001065) | 1.63899833 |
| 193 | Hemoptysis (HP:0002105) | 1.63037708 |
| 194 | Postural instability (HP:0002172) | 1.62948276 |
| 195 | Hemorrhage of the eye (HP:0011885) | 1.62762103 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.08193216 |
| 2 | OXSR1 | 4.42618731 |
| 3 | PRPF4B | 3.05917178 |
| 4 | BCR | 2.70867404 |
| 5 | WNK4 | 2.61156104 |
| 6 | RIPK4 | 2.60177240 |
| 7 | EPHB1 | 2.35699787 |
| 8 | PNCK | 2.32441528 |
| 9 | MET | 2.28859461 |
| 10 | CDK19 | 2.20535814 |
| 11 | EPHA4 | 2.18215068 |
| 12 | NEK6 | 2.17636379 |
| 13 | WNK1 | 2.11990999 |
| 14 | PKN1 | 2.07503325 |
| 15 | FGFR2 | 2.06161860 |
| 16 | PBK | 1.93016385 |
| 17 | CSNK1G3 | 1.90611798 |
| 18 | CSNK1A1L | 1.90126634 |
| 19 | FES | 1.86203375 |
| 20 | AKT3 | 1.81143471 |
| 21 | TNIK | 1.76066477 |
| 22 | FRK | 1.70514855 |
| 23 | TIE1 | 1.68740992 |
| 24 | MAPKAPK5 | 1.67227223 |
| 25 | BLK | 1.63403691 |
| 26 | PAK6 | 1.61583375 |
| 27 | SGK2 | 1.61335695 |
| 28 | MAP2K3 | 1.60090099 |
| 29 | CSNK1G1 | 1.56546965 |
| 30 | NTRK1 | 1.55964799 |
| 31 | CSNK1G2 | 1.55925767 |
| 32 | FGFR3 | 1.55008168 |
| 33 | PIK3CG | 1.54463596 |
| 34 | ARAF | 1.52659009 |
| 35 | TYK2 | 1.50438153 |
| 36 | NLK | 1.49491358 |
| 37 | TNK2 | 1.48846839 |
| 38 | MAPK12 | 1.48083429 |
| 39 | SGK3 | 1.45375389 |
| 40 | CASK | 1.36986483 |
| 41 | ZAP70 | 1.35825757 |
| 42 | SGK494 | 1.34919540 |
| 43 | SGK223 | 1.34919540 |
| 44 | CAMK2B | 1.34412083 |
| 45 | MAP3K3 | 1.34104161 |
| 46 | UHMK1 | 1.33498837 |
| 47 | CSK | 1.32686294 |
| 48 | DAPK2 | 1.31566601 |
| 49 | MAP3K7 | 1.29055729 |
| 50 | ICK | 1.27348248 |
| 51 | TRPM7 | 1.26585593 |
| 52 | JAK1 | 1.26486622 |
| 53 | MAP3K1 | 1.25321896 |
| 54 | RIPK1 | 1.24963345 |
| 55 | CAMK2D | 1.24109404 |
| 56 | FER | 1.22459653 |
| 57 | LIMK1 | 1.20457641 |
| 58 | IKBKE | 1.18938848 |
| 59 | ROCK2 | 1.12935362 |
| 60 | TTN | 1.12896068 |
| 61 | MAP4K1 | 1.09820431 |
| 62 | CAMKK2 | 1.09697047 |
| 63 | PAK3 | 1.07495260 |
| 64 | TEC | 1.04354319 |
| 65 | TAOK3 | 1.04118881 |
| 66 | MAP3K9 | 1.03342794 |
| 67 | PIK3CA | 1.02521802 |
| 68 | PRKAA2 | 0.99633521 |
| 69 | MAP3K14 | 0.98656603 |
| 70 | SYK | 0.97106191 |
| 71 | HCK | 0.97004468 |
| 72 | STK24 | 0.96848659 |
| 73 | BTK | 0.96596768 |
| 74 | ITK | 0.96259139 |
| 75 | FGR | 0.96123544 |
| 76 | MARK2 | 0.93459610 |
| 77 | MARK1 | 0.92849247 |
| 78 | IRAK1 | 0.92797086 |
| 79 | CDK5 | 0.92316354 |
| 80 | CAMK2G | 0.91379466 |
| 81 | GRK6 | 0.90912369 |
| 82 | JAK2 | 0.88385330 |
| 83 | TGFBR2 | 0.87871732 |
| 84 | PINK1 | 0.86912191 |
| 85 | KSR2 | 0.82586462 |
| 86 | CDK14 | 0.81694669 |
| 87 | TBK1 | 0.81600313 |
| 88 | PDPK1 | 0.80375038 |
| 89 | CAMK2A | 0.79398849 |
| 90 | RET | 0.78844812 |
| 91 | CLK1 | 0.78493511 |
| 92 | IRAK2 | 0.77726440 |
| 93 | FGFR4 | 0.77561898 |
| 94 | ERBB4 | 0.75918696 |
| 95 | CAMK4 | 0.75675635 |
| 96 | STK38 | 0.74702127 |
| 97 | GRK1 | 0.74121068 |
| 98 | TYRO3 | 0.74100767 |
| 99 | TESK2 | 0.73992465 |
| 100 | BUB1 | 0.73818370 |
| 101 | EPHA3 | 0.72606735 |
| 102 | PTK2B | 0.72308651 |
| 103 | INSRR | 0.71973649 |
| 104 | CAMK1 | 0.71911513 |
| 105 | CAMKK1 | 0.71753367 |
| 106 | JAK3 | 0.70883871 |
| 107 | HIPK2 | 0.70606600 |
| 108 | ACVR1B | 0.70569741 |
| 109 | IKBKB | 0.68045548 |
| 110 | IRAK4 | 0.67707501 |
| 111 | STK11 | 0.67297286 |
| 112 | PRKCE | 0.66475481 |
| 113 | CDK15 | 0.66275873 |
| 114 | TXK | 0.65411304 |
| 115 | MAP3K13 | 0.65265647 |
| 116 | BMPR1B | 0.64073318 |
| 117 | ERN1 | 0.63717348 |
| 118 | CDC42BPA | 0.63240158 |
| 119 | CSF1R | 0.62760906 |
| 120 | CDK18 | 0.62416589 |
| 121 | YES1 | 0.61719920 |
| 122 | MAPK15 | 0.61624228 |
| 123 | MYLK | 0.61417984 |
| 124 | PDGFRB | 0.60630515 |
| 125 | DYRK2 | 0.59658502 |
| 126 | LCK | 0.59385460 |
| 127 | PRKCQ | 0.58883399 |
| 128 | PRKCH | 0.58091658 |
| 129 | NUAK1 | 0.57566308 |
| 130 | MAP3K6 | 0.57364752 |
| 131 | BRAF | 0.57270051 |
| 132 | CDK11A | 0.56618278 |
| 133 | MAPK7 | 0.56435918 |
| 134 | CSNK1A1 | 0.54703209 |
| 135 | PRKD1 | 0.54072614 |
| 136 | PKN2 | 0.53610619 |
| 137 | OBSCN | 0.53031002 |
| 138 | MELK | 0.52338011 |
| 139 | CSNK1D | 0.52070157 |
| 140 | MAP2K1 | 0.51649489 |
| 141 | DMPK | 0.51500651 |
| 142 | MARK3 | 0.50196694 |
| 143 | KIT | 0.48383951 |
| 144 | LMTK2 | 0.48216577 |
| 145 | MAP3K2 | 0.46136674 |
| 146 | WNK3 | 0.45279294 |
| 147 | BMPR2 | 0.45014352 |
| 148 | PDK1 | 0.44547469 |
| 149 | CDK3 | 0.42503210 |
| 150 | MST4 | 0.41814586 |
| 151 | PHKG2 | 0.40562355 |
| 152 | PHKG1 | 0.40562355 |
| 153 | MAPK10 | 0.40500798 |
| 154 | DYRK1A | 0.38328248 |
| 155 | MAP2K2 | 0.38187918 |
| 156 | RPS6KA5 | 0.38155356 |
| 157 | FYN | 0.38006065 |
| 158 | MUSK | 0.37781735 |
| 159 | LATS1 | 0.36734266 |
| 160 | PRKG1 | 0.36668819 |
| 161 | PRKD3 | 0.35102813 |
| 162 | PRKACB | 0.35038189 |
| 163 | CSNK1E | 0.34042696 |
| 164 | NTRK2 | 0.32997226 |
| 165 | PDK2 | 0.32502382 |
| 166 | SGK1 | 0.30847686 |
| 167 | GRK5 | 0.30732340 |
| 168 | CAMK1G | 0.30156648 |
| 169 | GSK3A | 0.29976524 |
| 170 | PRKACA | 0.29823632 |
| 171 | NTRK3 | 0.29803573 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.31897346 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.25559112 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.67414188 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.50573001 |
| 5 | Phototransduction_Homo sapiens_hsa04744 | 3.44281607 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.65606545 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.49975103 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.34989301 |
| 9 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.81841853 |
| 10 | Protein export_Homo sapiens_hsa03060 | 1.79903053 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.76380189 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.74832267 |
| 13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.74689013 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 1.63437364 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.57752396 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.56487545 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.52973969 |
| 18 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.51397050 |
| 19 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.50566055 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.49160102 |
| 21 | Platelet activation_Homo sapiens_hsa04611 | 1.48734062 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42001016 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.38371851 |
| 24 | Axon guidance_Homo sapiens_hsa04360 | 1.37434775 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.33722923 |
| 26 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.33200671 |
| 27 | Morphine addiction_Homo sapiens_hsa05032 | 1.31063706 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.29678556 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.28629824 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.27264055 |
| 31 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.26679382 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.24564246 |
| 33 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.23587227 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.20926217 |
| 35 | Insulin resistance_Homo sapiens_hsa04931 | 1.19487463 |
| 36 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.18910990 |
| 37 | Cocaine addiction_Homo sapiens_hsa05030 | 1.17718394 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.13289859 |
| 39 | Tight junction_Homo sapiens_hsa04530 | 1.12946290 |
| 40 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.10870252 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08093080 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.08072169 |
| 43 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.07252669 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.06985650 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.05707453 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04069968 |
| 47 | Nicotine addiction_Homo sapiens_hsa05033 | 1.03251950 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99308073 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98994675 |
| 50 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98879727 |
| 51 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.98834375 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.98735304 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96549661 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96273456 |
| 55 | Circadian entrainment_Homo sapiens_hsa04713 | 0.95986244 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.95742750 |
| 57 | Long-term depression_Homo sapiens_hsa04730 | 0.95028712 |
| 58 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.93290836 |
| 59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92757532 |
| 60 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.91637251 |
| 61 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91595251 |
| 62 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.89772334 |
| 63 | Tuberculosis_Homo sapiens_hsa05152 | 0.89033233 |
| 64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88852726 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87899326 |
| 66 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87511637 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87157351 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.86308259 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86191793 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84766573 |
| 71 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.84635274 |
| 72 | Amoebiasis_Homo sapiens_hsa05146 | 0.83708001 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.83651599 |
| 74 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.82384916 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.80896317 |
| 76 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80781040 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80665433 |
| 78 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80106197 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79986470 |
| 80 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.79514542 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.78625776 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77567514 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76355737 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75625683 |
| 85 | Circadian rhythm_Homo sapiens_hsa04710 | 0.75424709 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.75238415 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.74840903 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74681372 |
| 89 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74187372 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.74160351 |
| 91 | Malaria_Homo sapiens_hsa05144 | 0.74026442 |
| 92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.74020094 |
| 93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.73440405 |
| 94 | Salivary secretion_Homo sapiens_hsa04970 | 0.73310794 |
| 95 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73291892 |
| 96 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.73220104 |
| 97 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73107948 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.72989264 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.72905720 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71964742 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70928141 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70916337 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70521051 |
| 104 | Pertussis_Homo sapiens_hsa05133 | 0.70217952 |
| 105 | Parkinsons disease_Homo sapiens_hsa05012 | 0.69807830 |
| 106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.69588597 |
| 107 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69266179 |
| 108 | Olfactory transduction_Homo sapiens_hsa04740 | 0.68797015 |
| 109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.68640120 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.68408335 |
| 111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.68279540 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67280995 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.66159403 |
| 114 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65668293 |
| 115 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65489696 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.65090942 |
| 117 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64554515 |
| 118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64433204 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64395253 |
| 120 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64301787 |
| 121 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.63859151 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | 0.63390661 |
| 123 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63352028 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.61710209 |
| 125 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60638032 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59357614 |
| 127 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.58052877 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57834069 |
| 129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56458251 |
| 130 | Legionellosis_Homo sapiens_hsa05134 | 0.55602586 |
| 131 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55382201 |
| 132 | Focal adhesion_Homo sapiens_hsa04510 | 0.54558362 |
| 133 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54521255 |
| 134 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54303442 |
| 135 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54028917 |
| 136 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53702272 |
| 137 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.52791451 |
| 138 | Long-term potentiation_Homo sapiens_hsa04720 | 0.52206759 |
| 139 | Glioma_Homo sapiens_hsa05214 | 0.51605974 |
| 140 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51218578 |
| 141 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49964515 |
| 142 | Taste transduction_Homo sapiens_hsa04742 | 0.49339601 |
| 143 | Renin secretion_Homo sapiens_hsa04924 | 0.48279037 |
| 144 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47741063 |
| 145 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47313615 |
| 146 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.46694308 |
| 147 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46071825 |
| 148 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46019744 |
| 149 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44918017 |
| 150 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43648934 |
| 151 | Gap junction_Homo sapiens_hsa04540 | 0.43450538 |
| 152 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.42879038 |
| 153 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.41450568 |
| 154 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41401536 |
| 155 | RNA polymerase_Homo sapiens_hsa03020 | 0.40337251 |
| 156 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.39275604 |
| 157 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39207029 |
| 158 | Basal transcription factors_Homo sapiens_hsa03022 | 0.35781236 |
| 159 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.35044344 |
| 160 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.34738113 |
| 161 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.33532547 |
| 162 | ABC transporters_Homo sapiens_hsa02010 | 0.31048860 |
| 163 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.30456254 |
| 164 | Peroxisome_Homo sapiens_hsa04146 | 0.28662658 |

